Loomis Sayles & Co. L P Buys 28,790 Shares of Option Care Health, Inc. (NASDAQ:OPCH)

Loomis Sayles & Co. L P grew its stake in shares of Option Care Health, Inc. (NASDAQ:OPCH) by 2.8% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,050,549 shares of the company’s stock after buying an additional 28,790 shares during the period. Loomis Sayles & Co. L P owned 0.62% of Option Care Health worth $24,372,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently modified their holdings of OPCH. Murphy & Mullick Capital Management Corp purchased a new position in Option Care Health during the fourth quarter worth about $26,000. UMB Bank n.a. grew its holdings in shares of Option Care Health by 41.7% during the fourth quarter. UMB Bank n.a. now owns 1,176 shares of the company’s stock worth $27,000 after purchasing an additional 346 shares in the last quarter. Signaturefd LLC increased its position in shares of Option Care Health by 487.9% in the fourth quarter. Signaturefd LLC now owns 1,211 shares of the company’s stock worth $28,000 after purchasing an additional 1,005 shares during the last quarter. Quarry LP raised its stake in Option Care Health by 327.7% in the third quarter. Quarry LP now owns 3,430 shares of the company’s stock valued at $107,000 after purchasing an additional 2,628 shares in the last quarter. Finally, Blue Trust Inc. lifted its position in Option Care Health by 16.9% during the fourth quarter. Blue Trust Inc. now owns 4,703 shares of the company’s stock valued at $109,000 after purchasing an additional 681 shares during the last quarter. 98.05% of the stock is owned by hedge funds and other institutional investors.

Option Care Health Stock Down 1.3 %

OPCH stock opened at $34.73 on Friday. The business has a 50 day moving average of $32.47 and a 200 day moving average of $28.44. The firm has a market cap of $5.70 billion, a PE ratio of 29.18, a price-to-earnings-growth ratio of 2.30 and a beta of 1.33. Option Care Health, Inc. has a twelve month low of $21.39 and a twelve month high of $35.53. The company has a quick ratio of 1.32, a current ratio of 1.73 and a debt-to-equity ratio of 0.77.

Analyst Upgrades and Downgrades

Several analysts have recently weighed in on OPCH shares. Jefferies Financial Group upgraded shares of Option Care Health from a “hold” rating to a “buy” rating and raised their price objective for the company from $26.00 to $35.00 in a research report on Thursday, January 23rd. UBS Group began coverage on Option Care Health in a research note on Thursday, December 5th. They set a “neutral” rating and a $26.00 price target for the company. Bank of America upgraded Option Care Health from a “neutral” rating to a “buy” rating and increased their price objective for the company from $26.00 to $33.00 in a research report on Monday, January 13th. Barrington Research boosted their target price on Option Care Health from $33.00 to $38.00 and gave the stock an “outperform” rating in a research report on Thursday, February 27th. Finally, JPMorgan Chase & Co. increased their price target on shares of Option Care Health from $40.00 to $41.00 and gave the company an “overweight” rating in a research report on Thursday, March 6th. Two analysts have rated the stock with a hold rating and six have given a buy rating to the stock. According to data from MarketBeat, Option Care Health currently has a consensus rating of “Moderate Buy” and a consensus target price of $33.00.

Insider Transactions at Option Care Health

In related news, insider Michael Bavaro sold 30,996 shares of the company’s stock in a transaction dated Friday, February 28th. The shares were sold at an average price of $33.26, for a total value of $1,030,926.96. Following the transaction, the insider now owns 44,974 shares in the company, valued at $1,495,835.24. The trade was a 40.80 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Insiders own 0.64% of the company’s stock.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.